Express Scripts sues FTC over report blaming pharmacy middlemen for high drug costs
At issue is a report released by the FTC in July called: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” Express Scripts claims in the lawsuit that the report “is seventy-four pages of unsupported innuendo” leveled against it and other PBMs.
Pharmacy benefit managers, version 2.0 (post J&J lawsuit)
2025 and 2026, they're right around the corner, and many employers are making changes now for 2025 or are anticipating changes for 2026, given a lot of the media attention around the lawsuits, prescription prices, the conversation around being a fiduciary, etc. It's really a pivotal time for pharmacy benefits.
Market is Growing at CAGR of 6.0%, Increasing Demand for Cost-Effective Drug Management Solutions Propels Market Growth.Pune, ...
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and ...
As prescription drug costs remains a significant, and largely bipartisan, issue for state and federal legislators, we ...
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug ...
Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a ...
3d
The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published by Pharmaceutical Strategies Group ("PSG") disclosed ...
A new Idaho law that goes into effect in January reforms pharmacy benefit managers to increase transparency and cut ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback